All posts by imreal

Iamfine.com supports the fight to cope with COVID-19


Iamfine daily call service

With the global spread of coronavirus, many people are being asked to help protect themselves and their communities through self-isolation. This can be an especially frightening prospect for elderly people that live alone.

Iamfine is announcing that as of today, it is waiving its fees for new customers as its way of supporting the fight to cope with the spread of the virus.

Iamfine is an automated daily phone check-in service that calls a person who lives alone once or twice a day at a predetermined time and prompts them to press 1 to confirm they are ok. If they miss their scheduled check-in, then Iamfine will alert the user’s list of friends and family and others by email, text or a call.

“Does anybody know that I am ok?” This can be a real concern for the elderly who are now being asked to socially distance themselves from their community. Iamfine provides the reassurance that their list of prearranged contacts will be alerted if they miss their check-in call even if they can not be in close contact.

Iamfine was created by two brothers caring for their mother in 2012, and has since grown to deliver over 1 million calls. It provides service directly to the public and to organizations that are responsible for the wellbeing of larger groups.

For more information on how Iamfine can assist you or your community, visit https://www.iamfine.com and use code APRIL2020.

Share article on social media or email:

Project HOPE Teams Up With Experts at Brown University to Provide COVID-19 Training for Health Workers


Project HOPE logo

“If just one country is unable to contain the spread of COVID-19, everyone around the world will continue to be at risk for a very long time,” said Rabih Torbay, President and CEO at Project HOPE.

Project HOPE today announced it is teaming up with the Center for Human Rights and Humanitarian Studies at the Watson Institute of Brown University to develop and implement a COVID-19 training program for health workers to rapidly scale-up response efforts in high-risk countries.

“As confirmed cases of COVID-19 increase here in the United States, we must not forget this is a global pandemic that requires a robust and well-coordinated global response. If just one country is unable to contain the spread of COVID-19, everyone around the world will continue to be at risk for a very long time,” said Rabih Torbay, President and CEO at Project HOPE. “That’s why we’re partnering with the experts at Brown University to develop a world-class infection control and prevention training for health workers in at-risk countries, and we’ll also make the curriculum publicly available so doctors and nurses worldwide can benefit.”

“We are excited to be partnering with Project HOPE on this important training. Health workers are the most valuable resource of any nation’s healthcare system, and we need to ensure that they are well trained all over the world to protect themselves and care for patients during this worldwide pandemic,” said Adam Levine, Director of the Center for Human Rights and Humanitarian Studies at the Watson Institute of Brown University.

This COVID-19 training will teach and evaluate trainees on core competencies, including biology and transmission mechanisms; infection prevention and control; contact tracing; screening and triage; diagnosis and management; stabilization and resuscitation; health facility operations and surge capacity; and risk communication and public health messaging. The training will utilize the Training-of-Trainers model to engage master trainers and coach new trainers, allowing Project HOPE and the Center for Human Rights and Humanitarian Studies to quickly build a cadre of competent instructors who can then teach the material to other health workers in their community.

To ensure health facilities worldwide can quickly benefit from this training, the curriculum is being designed for widespread replication and will be publicly available once finalized. Given global travel restrictions, Project HOPE and the Center for Human Rights and Humanitarian Studies are considering various platforms for training delivery, including teletraining as well as online, interactive training modules. Project HOPE plans to deliver this training in North Macedonia and Kosovo in the next month before further expansion to additional countries.

This training is only one part of a much larger COVID-19 response effort by Project HOPE, which includes supporting frontline health workers in China as well as expanding support into North Macedonia, Kosovo, Colombia, Indonesia and Ethiopia.

Project HOPE is one of the only international relief organizations with a response team on the ground in China for the COVID-19 outbreak. Over the past two months, Project HOPE has delivered a total of nearly 5 million facemasks as well as isolation gowns, protective coveralls, exam gloves, and other protective gear to hospitals in Hubei, Yunan, Jiangsu, Anhui, and Sichuan provinces and to Shanghai. Project HOPE is also providing lifesaving medical equipment to support patient care and treatment now and long into the future, including ventilators, medical air compressors, and disinfection machines.

For more information on Project HOPE’s response to the coronavirus outbreak, visit http://www.projecthope.org.

ABOUT PROJECT HOPE

Project HOPE operates around the world wherever the need is greatest, working side-by-side with health care workers and their communities, addressing the greatest public health challenges to enable people to live their best lives. We respond to disasters and health crises and stay on in communities long after disaster strikes to help find solutions to epidemics and any other neglected health needs.

ABOUT THE CENTER FOR HUMAN RIGHTS AND HUMANITARIAN STUDIES

The Center for Human Rights and Humanitarian Studies at Brown University’s Watson Institute for International and Public Affairs, is committed to promoting a more just, peaceful, and secure world by furthering a deeper understanding of global human rights and humanitarian challenges, and encouraging collaboration between local communities, academics, and practitioners to develop innovative solutions to these challenges.

Share article on social media or email:

RCare Reacts to COVID-19 Crisis with Release of Hospital Rapid Deployment Nurse Call Kits


RCare Rapid Deployment Nurse Call Kit

RCare Rapid Deployment Nurse Call Kit

“The overall risk from this virus is still unknown, but what we do know is that many hospitals and providers are being overwhelmed with patients,” said Myron Kowal, CEO of RCare. “We decided to quickly extend our technology capabilities to places where they are in dire need.”

RCare, Inc., maker of nurse call and monitoring solutions, announced today the release of their Rapid Deployment Wireless Nurse Call Kit created specifically for emergency situations. Designed for speed and ease-of-use, RCare’s Rapid Deployment Kit installs in only five minutes and offers a reliable, secure, 40-patient nurse call system in a box. RCare’s G4 platform provides best-in-class range to cover even the largest of campuses and deepen building penetration.

“The overall risk from this virus is still unknown, but what we do know is that many hospitals and providers are being overwhelmed with patients,” said Myron Kowal, CEO of RCare. “We decided to quickly extend our technology capabilities to places where they are in dire need.”

The plug-and-play system is preprogrammed by RCare’s expert technicians and ready for use immediately out of the box. It includes one small touchscreen server, one pendant for each resident or patient (up to 40), and four pagers. (Expansion kits are available.) Only one internet connection is required, and no landlines are necessary.

RCare Rapid Deployment Kit Includes:

  • NurseCall Master with Integrated Touchscreen Console
  • 40 Pushbutton Pendants (waterproof; reusable if disinfected or disposable)
  • 40 Clip-On Bed Signs
  • 4 Alpha-Numeric Apollo Pagers
  • G4 Master Receiver
  • 2 G4 Locators
  • Single-Input Serial Page Encoder 5W
  • Compact, Heavy Duty Pelican Case
  • Easy step-by-step instructions and link to instructive video

The touchscreen console displays incoming patient calls with an audible tone. Patient beds are outfitted with clip-on placards that correspond to patient call buttons, so caregivers know which patients are calling. The system can be deployed in only five minutes.

ABOUT RCare

RCare is a global provider of nurse call and personal emergency response systems for the entire spectrum of eldercare and senior living. Our components integrate into a variety of healthcare communication systems to create efficient and verifiable responses to medical emergencies. RCare works together with distribution partners to build individualized, flexible and seamless systems to enhance both caregiving and resident quality of life. Contact info@rcareinc.com or call 585-671-4144.

Share article on social media or email:

Lava Gel® Technologies, LLC creates product line for Acute Care Hospitals and the current challenges & risks associated with unprecedented patient demand


All healthcare foodservice departments should have a rapidly deployable, inexpensive contingency plan that can be implemented, on demand, in times of need.

Lava Gel Technologies today announced h°eats® pads-for-healthcare, a new way to ensure acute care hospitals have the tools to address the potential unprecedented demand for safe, hot food services as a result of the global health pandemic caused by the Coronavirus (COVID-19).

H°eats pads-for-healthcare allows hospital food services the ability to keep tray-lines operational when a steamtable becomes inoperative or if the need for mobile, flexible and agile food services is required. H°eats pads-for-healthcare is a water-activated, flame-free, self-heating pad that is placed between two food pans. It provides safe, reliable, flame free heat for up to two hours and offers a new way for health care foodservice departments to continue patient feeding operations when steamtable equipment becomes in-operable or the demands on the food services extends beyond the limitations of the existing infrastructure. H°eats pads-for-healthcare’s low cost and 30 second activation, are the perfect choice for a foodservice department’s meal service contingency plan. H°eats pads-for-healthcare also allows foodservice departments the ability to scale up their feeding operations immediately, to meet the demands of increasing patient census during emergency situations. H°eats pads-for-healthcare integrates seamlessly with existing equipment and supplies and does not require accessories or special equipment to purchase.

“All healthcare foodservice departments should have a rapidly deployable, inexpensive contingency plan that can be implemented, on demand, in times of need that will ensure the delivery of hot, nourishing meals to their patients. With today’s unpredictable demands on a hospital’s foodservice department, a safe, simple and reliable contingency plan to scale up or ensure continued meal deliveries, regardless of a lack of additional equipment capacity or un-expected equipment failures, is a must,” says Anthony Russo, Director of Business Development at Lava Gel Technologies, LLC.

Jimmy Frischling, Managing Partner at Branded Hospitality Group LLC, added, “The issue facing Acute Care Hospitals represents an immediate and material threat to our healthcare system and while there are many pressing issues hospitals will need to address as a result of the expected spike in demand for health services, we feel LGT can specifically be an ally to the healthcare industry as it pertains to its Food Services that are also going to be under tremendous pressure.”

Features and benefits of h°eats pads-for-healthcare include:

  • Activates and operational in less than 30 seconds
  • Low cost per activation
  • Safe, non-toxic, reliable flame-free heat
  • Requires up to 90% less water than traditional food warming methods
  • No special equipment to operate, integrates with existing equipment and supplies
  • First orders can be shipped within 24 hours *subject to availability


H°eats pads-for-healthcare are available now in full and half pan sizes and can be used with 2 – ½ or 4” deep pans and are $3.00 per food pan activation. For more information on h°eats pad-for-healthcare contact arusso@lavagelusa.com

About Lava Gel Technologies LLC

Lava Gel Technologies LLC., a subsidiary of Lava Gel USA Is a US based company specializing in the development and production of innovative, safe, reliable and simple to operate products that provide flame-free heat, that can be used anytime, anywhere and by anyone. Products that are “Powered by Lava Gel®” are currently used in the cosmetic, healthcare, foodservice and consumer goods markets. The products developed by Lava Gel Technologies LLC are covered by numerous US and Foreign patents.

About Branded Hospitality Group LLC

Branded Hospitality Group LLC (“Branded”), is an investment & solutions platform based in New York City. Branded leverages its ecosystem of hospitality venues, industry expertise and deep relationships to connect Hospitality Industry Technology, Food-Tech, Prop-Tech and Innovative companies with capital and customers. Branded is at the intersection of hospitality, technology, innovation and capital.

Share article on social media or email:

Donate2it lowers crowdrise fees to help those in need during the Pandemic


Donate2it Counters

Crowd rising platforms have been able to help many people with financial donations from others who donate various amounts. The total donations can add up to a substantial amount that can make a difference in the lives of those that need it most.

In this time of need, many fundraising platforms are available. Some describe themselves as free. However, when a person clicks to donate, the contribution automatically adds a “15% tip” unless a donor catches it and changes it. A 2.5% credit card processing fee is also added meaning only 82.5% goes to what people are donating too. Typically, with a 45 to 75 day distribution time before a check is sent.

One particular platform, Donate2it, normally has a flat fee of 5% which is used to pay web services, insurance, licensing. Donate2it pays no dividends nor salaries. Stripe charges 2.2% for processing online transactions. There are no fees for a check contribution.

During this time, for the next few months, or as long as needed, Donate2it is dropping fees from 5% to 2.5%. With the 2.2% Stripe fee, that means that 95.3% of the money contributed will go to the cause or need.

Donate2it normally turns around the disbursement once the contribution has cleared. Usually in about 3 days.

Anyone can sign up for any type of fundraiser – private or nonprofit. Current fundraisers are all for nonprofits with a match provided from the MatchingFund.org. A nonprofit can apply to receive a matching grant by signing into Donate2it and requesting a match. There is a list of very successful campaigns. Overall, since inception Donate2it with the MatchingFund has raised about $475,000. Many campaigns had a provided match. Up to $130,000 in total match has been provided so far.

The MatchingFund.org is a 501(c)(3) Charitable organization. Tax deductible donations can be made directly too TheMatchingFund.org. These donations give the board of directors the flexibility to provide Matching Funds to worthy charities and causes that might not otherwise have funds for matching donations. Donations made to individuals and other certain causes may not be tax deductible as defined by the IRS.

Share article on social media or email:

Energage Launches Podcast Series; Offers Tips to Maintain Connection With Employees as Pandemic Evolves


“This crisis will have many phases, all of which will require companies to keep the lines of communication open with what is the most disparate workforce this economy has ever experienced,” said Doug Claffey, Energage founder and chief strategy officer.

Energage, the leader in helping companies measure, shape, and showcase their culture through a fully unified SaaS platform, today announced it has launched a free, on-demand podcast series aimed at helping organizations maintain a connection with employees as the COVID-19 pandemic evolves.

“This crisis will have many phases, all of which will require companies to keep the lines of communication open with what is the most disparate workforce this economy has ever experienced,” said Doug Claffey, Energage founder and chief strategy officer. “Our business was founded 14 years ago with the purpose of making the world a better place to work together. It is in that spirit that we are working hard to create content and solutions that provide organizations the support they need to effectively manage the employee experience.”

The podcast series will feature Claffey, as he offers organizations tips around how to best gather feedback from employees during such an uncertain, dynamic, and complex situation. The episodes, focused on delivering actionable tips, will be no more than three minutes long, and released frequently to help organizations focus their efforts and adapt quickly to fast-changing conditions. Subscribers will be alerted when a new episode is posted.

Click here to listen to the first podcast episode, titled “COVID-19: Why Employee Communication is More Important Than Ever,” and subscribe to receive alerts when new episodes are available. The second episode is scheduled to post on Thursday, March 19th.

About Energage

Energage offers a fully unified SaaS platform, plus support and professional services, to help organizations recruit and retain the right talent. As a B-Corporation founding member, Energage has committed itself to the purpose of making the world a better place to work together. Based on 14 years of culture research, the engine behind 51 Top Workplaces programs across the country, and data gathered from over 20 million employees at 60,000 organizations, Energage has isolated the 15 drivers of engaged cultures that are critical to the success of any business, and developed the tools and expertise to help organizations measure, shape, and showcase their unique culture to achieve a sustainable competitive advantage. For more information, please visit energage.com. Follow us on Twitter @teamenergage and Facebook and LinkedIn @energage.

Share article on social media or email:

Aira Adds Apple and Tesla Veteran Jeff Risher as Chief Strategy Officer & General Counsel


Jeff Risher, Chief Strategy Officer & General Counsel, Aira

FreePower has the potential to re-energize the wireless charging industry and deliver on the promise of convenience. It can ignite entirely new ecosystems providing business opportunities and stronger charging experiences across so many different industries.

Aira Inc., makers of FreePower™ free-position wireless charging technology, is excited to announce it has added Apple and Tesla veteran Jeff Risher to its executive team as Chief Strategy Officer and General Counsel.

In this role, Jeff will lead the company’s business development and corporate strategy, as well as oversee Aira’s legal matters, IP strategy and technology partnerships. The hire, Aira’s most senior to date, adds important expertise as the company aims to transform wireless charging and expand its reach into key verticals including consumer electronics, automotive, furniture, and hospitality.

Jeff brings two decades of experience and leadership from technology and automotive brands including Apple, Tesla, and Faraday Future in technology, IP strategy, licensing, litigation, mergers & acquisitions, and strategic partnerships. He has been recognized as one of the “Top IP Strategists in the World” by Intellectual Asset Management Magazine (IAM) and has served as a key advisor for fast growth tech startups.

“We are excited to welcome Jeff to Aira as he brings a wealth of experience and proven judgment in areas that are critical to our growth and success,” said Jake Slatnick, co-founder and CEO of Aira. “Jeff is a seasoned technology strategist, IP expert and deal maker, and has experience at some of the most innovative and well-known brands in the world. He will be instrumental towards our mission to evolve wireless charging forever.”

“From the time I met Jake and Eric, and saw the technology working, I knew I had to be a part of this,” said Risher. “It’s rare to come across an opportunity like Aira where the present needs, future direction and its transformative technology are so well matched with my strengths and background. FreePower has the potential to re-energize the wireless charging industry and deliver on the promise of convenience. It can ignite entirely new ecosystems providing business opportunities and stronger charging experiences across so many different industries.”

Through inventive hardware and software, Aira has transformed the wireless charging experience with FreePower™. Engineered from the ground up, FreePower™ achieves complete freedom of placement with its built-in-house chipset and foundationally new wireless power transmitting technology. Sophisticated algorithms enable multi-device charging with rapid device detection and precision power delivery. Aira’s FreePower™ technology is an elegant solution that pushes boundaries making good on the fundamental promise of wireless charging – convenience.

Operating on top of the Qi Standard, FreePower™ is compatible with all major devices including those from Apple, Samsung, and Google.

To learn more about Aira and FreePower™, visit http://www.airapower.com. To access additional media assets, view the press kit HERE.

About Aira

Aira, founded in 2017 by Jake Slatnick and Eric Goodchild, is the creator of FreePower™, a free-position, multi-device wireless charging technology. With a mission to evolve wireless charging, Aira is forming FreePower™ technology partnerships across several verticals including consumer electronics, automotive, furniture and hospitality. Aira’s first technology partner, Nomad Goods, is slated to bring FreePower™ to market with their Base Station Pro in 2020. Aira is headquartered in Chandler, Arizona.

Share article on social media or email:

Epinephrine Nasal Spray Demonstrates Bioequivalent Exposure and Absorption Rate Compared to Epinephrine Injectors


AAAAI Logo

“Based on these results, nasal spray epinephrine has the potential to be a needle-free alternative to intramuscular epinephrine and could help to alleviate some of those delays in treatment.” – Richard F. Lockey, MD, FAAAAI

According to data originally scheduled to be presented at the 2020 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) before its cancellation due to the situation with coronavirus disease 2019 (COVID-19), epinephrine nasal spray could be an effective needle-free alternative for treating anaphylaxis.

“There’s a stigma associated with needles, and fears over administrating epinephrine to oneself or someone else can cause delays in medication administration. These delays can lead to emergency situations that can put the patient in real danger,” said Richard F. Lockey, MD, FAAAAI, one of the authors of the three studies presented across two abstracts that are now published in an online supplement to The Journal of Allergy and Clinical Immunology. “Based on these results, nasal spray epinephrine has the potential to be a needle-free alternative to intramuscular epinephrine and could help to alleviate some of those delays in treatment.”

The first study (EPI 04), titled Comparison of the Pharmacokinetics and Pharmacodynamics of Epinephrine After Intranasal (IN), Intramuscular (IM) and Subcutaneous (SC) Administration in Three Landmark Studies, evaluated three dosing methods to assess the pharmacokinetics of epinephrine in 36 subjects. A 1 mg dose of epinephrine nasal spray, a 0.3 mg and 0.5 mg dose given by intramuscular injection, and a subcutaneous administration were studied. The study also tested epinephrine nasal spray in patients with induced allergic rhinitis, alongside the previously mentioned doses. Epinephrine nasal spray demonstrated a bioequivalent exposure to a 0.3 mg intramuscular dose that was given once by a needle and syringe. It was also more rapidly absorbed than administration by needle and syringe. The hemodynamic response (a greater or more rapid increase in systolic blood pressure and heartrate) saw significant improvements with the epinephrine nasal spray.

A second study (EPI 03), A Phase 1, Five-Period, Five-Treatment, Randomized Crossover Study of the Pharmacokinetics (PK) and Pharmacodynamics (PD) of Epinephrine After Administration of Intranasal ARS-1 and Intramuscular Epinephrine to Healthy Volunteers, presented a closer look at specific numbers. In this study, 70 healthy adults were randomized in a cross-over design to receive different combinations of epinephrine doses and dosing methods.

Subjects received 1 mg of intranasal epinephrine once or twice, 0.3 mg of intramuscular once or twice, or 0.5 mg of intramuscular once. Hemodynamic measurements were taken and extensive pharmacokinetic sampling occurred. Epinephrine nasal spray was again found to be bioequivalent to intramuscular dosing. Based on the amount of time it took the medication to reach maximum concentration, the epinephrine nasal spray absorption rate was faster than intramuscular injections (20 minutes versus 45 minutes). The epinephrine nasal spray had a higher peak of epinephrine concentration compared to the 0.3 mg dose, but 16% lower compared to 0.5 mg doses. Overall, the epinephrine nasal spray delivered a more consistent exposure and hemodynamic response within the first 20 minutes.

A third study (EPI 07), A Phase 1, Five-Period, Five-Treatment, Randomized Crossover Study of the Pharmacokinetics of Epinephrine After Administration of Intransal ARS-1 or EpiPen to Healthy Volunteers, included administration of a single and repeat (twice) dose of 1 mg epinephrine nasal spray compared to single and repeat 0.3mg EpiPen injection in 36 subjects, with blood pressure and heartrate measurements taken every five minutes. Epinephrine nasal spray was again found to have bioequivalent exposure with comparable peak concentrations compared to intramuscular dosing by 0.3 mg EpiPen. The epinephrine nasal spray absorption rate was also faster than EpiPen injections.

These studies also took note of any adverse events that occurred due to the nasal administration of epinephrine. Overall it was well-tolerated with mostly mild adverse events and no significant nasal pain or irritation.

“Epinephrine nasal spray has shown promise in these completed studies,” Dr. Lockey added. “With a lack of serious adverse events, comparable rates of absorption and the consistent reliability when it comes to delivery, the ARS-1 product, which will be called Neffy, represents a step forward in patient care for the treatment of severe systemic allergic reactions to help prevent anaphylaxis.”

Visit aaaai.org to learn more about anaphylaxis. This research was published in an online supplement to The Journal of Allergy and Clinical Immunology.

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has over 7,000 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

###

Share article on social media or email:

AEGIS Energy Risk Adds Interest Rate Derivatives Veteran


News Image

“I am excited to join the firm at a time when interest rate and commodity price volatility are front and center and look forward to allowing our clients to manage both from an integrated platform,” said Rob Sabo.

AEGIS Energy Risk (“AEGIS”), the leading fintech and advisory solutions provider for commodity and rate hedging, announced today that Robert Sabo has joined the company as its Director of Rate Advisory.

“Our clients look to us as a trusted advisor for managing commodity price risk,” said Bryan Sansbury, CEO of AEGIS. “Given the capital intensity and significant floating rate risk in our clients’ businesses, interest rate advisory is a natural extension to our platform and services.”

Robert joins AEGIS from Rabobank, where he most recently served as an Executive Director, responsible for providing interest rate and commodity advisory and derivative hedging product solutions for the global bank’s domestic food production and agricultural client base.

Before joining Rabobank, Robert spent over 20 years in interest rate and commodity consulting, derivatives hedging, and leadership roles covering a broad range of middle market and large corporate clientele across a multitude of industries with firms such as HedgeWerks Risk Management, ABN AMRO Bank, LaSalle Bank, and CIBC.

Robert graduated with a Bachelor of Business Administration degree in Finance and Business Economics with Honors from the University of Michigan. Robert has also successfully received a Master of Business Administration degree in Finance from the University of Chicago.

“AEGIS is the recognized leader in hedge advisory. The platform – including View, Engage and Flow – is reshaping the way producers manage commodity and rate risk,” said Robert Sabo. “I am excited to join the firm at a time when interest rate and commodity price volatility are front and center and look forward to allowing our clients to manage both from an integrated platform.”

About AEGIS Energy Risk

AEGIS Energy Risk is the leading fintech and advisory solutions provider for commodity and rate hedging markets, having been recognized as the Hedge Advisor of the Year for the last 3 years by Energy Risk Magazine. AEGIS’ proprietary Engage and Flow software platforms and unmatched depth in the commodity and rate hedging markets combine to power companies, investors and lenders as they deploy, grow, and protect capital. For more information, please visit AEGIS-energy.com.

Share article on social media or email:

Dr. Mary Beth Fasano Begins Term as 2020-2021 AAAAI President


Mary Beth Fasano, MD, MSPH, FAAAAI

“…I had hoped to greet many of you personally during our 2020 Annual Meeting in Philadelphia, however the unprecedented events related to the current coronavirus pandemic made that impossible and have reshaped our professional and personal lives in ways none of us could have imagined.”

The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to introduce its 2020-2021 President, Mary Beth Fasano, MD, MSPH, FAAAAI.

The AAAAI is the largest professional membership organization for allergist/immunologists, other medical specialists, allied health and related healthcare professionals—all with a special interest in the research and treatment of allergic and immunologic diseases, including asthma.

“I am thrilled to have the opportunity to serve the AAAAI as your President for the next year. I am preceded in this role by outstanding leaders in the field—many of whom have served as mentors instrumental in my career development. I had hoped to greet many of you personally during our 2020 Annual Meeting in Philadelphia, however the unprecedented events related to the current coronavirus pandemic made that impossible and have reshaped our professional and personal lives in ways none of us could have imagined. As an organization, we are composed of members with unique expertise and skills that can help our patients and our community through this most challenging time. I look forward to our opportunities to collaborate on important issues confronting our specialty and the patients we serve over the next year,” said Dr. Fasano.

A native of Baltimore, Maryland, Dr. Fasano’s passion for allergy/immunology began as a pediatric resident and then fellow at Johns Hopkins. Following fellowship she spent 10 years at Wake Forest University/Bowman Gray School of Medicine, two years in private allergy practice in Greensboro, North Carolina, and is now in the Division of Immunology at the University of Iowa. She has been fortunate to have had the support of many mentors over the years at Johns Hopkins, Wake Forest and the University of Iowa. “Their direction, feedback and friendships have shaped my career path and provided numerous opportunities for advancement and success. I owe them a huge thank you,” said Dr. Fasano.

At the University of Iowa since 2004, Dr. Fasano is involved in clinical practice and serves as the Allergy/Immunology Fellowship Program Director and medical consultant for Iowa’s severe combined immunodeficiency newborn screening program. She is board certified by the ABP and the ABAI and is participating in Maintenance of Certification with both certifying boards.

In addition to leadership roles within the AAAAI, Dr. Fasano served as Vice President and President of the Iowa Society of Allergy, Asthma and Immunology (2011-2014). Her involvement in medical education has included service on the University of Iowa Graduate Medical Education Committee, membership on the Accreditation Council for Graduate Medical Education (ACGME) A/I Milestone Project Working Group and membership on the ACGME A/I Review Committee. She has served on the Board of Directors of the American Board of Allergy and Immunology (ABAI), including one year as Chair (2011-2012), and recently returned to the ABAI Board of Directors as the liaison to the American Board of Pediatrics (ABP).

Dr. Fasano received her MD from Texas Tech University Health Sciences Center in Lubbock, Texas. Prior to attending medical school, she received an MSPH from the University of North Carolina Gillings School of Global Public Health in Chapel Hill, North Carolina. She also completed a one year research fellowship in infectious diseases at Wake Forest University in Winston-Salem, North Carolina before starting her allergy/immunology fellowship. Her research experiences at Wake Forest related to the role of IL-1 in sepsis syndrome, followed by research during fellowship in the area of complement deficiencies and other primary immunodeficiency disorders, served as the foundation for an ongoing fascination with congenital immunodeficiencies and other immune-based disorders. “However, it has always been the privilege of caring for individual patients that has sustained my passion for our field of allergy/immunology,” said Dr. Fasano.

She met her husband Mark, a native of Amarillo, Texas, during their first year of medical school in Lubbock. They have shared many adventures over the years as their professional careers in medicine have evolved. They are also the proud parents of two children, Vince and Elena, and recently welcomed a daughter-in-law (Vince’s wife Megan) to the family.

Dr. Fasano’s family has provided tremendous support over the years. “Their patience and understanding of the challenges of a career in medicine while raising a family has been fabulous. I am truly blessed,” she said.

The American Academy of Allergy, Asthma & Immunology (AAAAI) represents allergists, asthma specialists, clinical immunologists, allied health professionals and others with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI has over 7,000 members in the United States, Canada and 72 other countries. The AAAAI’s Find an Allergist/Immunologist service is a trusted resource to help you find a specialist close to home.

###

Share article on social media or email: